NCT04095312Unknown不适用
A Prospective, Single-center, Single-group Clinical Study for Evaluating the Clinical Safety and Effectiveness of the Automated Robotic Robot, Revo-i Surgical Robot System (Model MSR-5100), Used for General Endoscopic Surgery.
适应症
干预措施
试验速览
- 阶段
- 不适用
- 入组人数
- 33
- 试验地点
- 2
- 主要终点
- Operation success rate
研究概览
简要总结
This study is based on the ergonomic features of the most common surgical procedures, which require advanced techniques and relatively difficult operations, such as pancreatobiliary surgery, prostatectomy, nephrectomy, colon and rectal resection. This study id designed to verify the clinical safety and effectiveness of 'Revo-i Surgical Robot System (Model MSR-5100), developed by Mirae Company to overcome the limitations of general laparoscopic surgery.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 19 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All of the following selection criteria must be met to be enrolled in this clinical trial.
- •Common Standard
- •Adults over 19
- •Voluntary consent to clinical research and willingness to comply with the protocol
- •Pancreaticobiliary tract area surgery
- •A person deemed to need surgery for pancreaticobiliary tract due to one or more of the following reasons:
- •Benign and borderline periampullary cancer
- •Resectable masses (biliary cancer, pancreatic cancer, duodenal cancer, AoV cancer, etc.) Congenital gallbladder cysts
- •Endoscopic treatment of adenocarcinoma and early stage lesions of ampulla
- •There is no major organ or vascular invasion
- •Lack of severe pancreatitis and cholangitis
- •Patients considering laparoscopic surgery who cannot perform da Vinci robot surgery due to personal expense
- •Others who have been diagnosed with high latitude pancreaticobiliary tract surgery according to the researcher's judgment
- •Prostatectomy
- •Persons deemed necessary for prostatectomy in the following cases:
- •The prostate is at low risk or medium risk, and the tumor is located at the local site without metastasis Criteria for Prostate Risk Group Prostate low risk group Prostate Cancer Stage (T1-T2a) and Gleason Grade ≤6 and PSA <10ng / ml Risk group in the prostate Prostate cancer stage (T2b-T2c) or Gleason grade 7 or10 ng / ml ≤ PSA ≤ 20 ng / ml
- •* Reference) NCCN (National Comprehensive Cancer Network), 2015
- •Others who have been diagnosed as requiring prostate surgery according to the researcher's judgment
- •Nephrectomy
- •Persons deemed necessary for renal resection should:
- •Localized renal cell carcinoma without metastasis to organs other than the kidney Stage 1A, IB, II, III
- •* Reference) NCCN (National Comprehensive Cancer Network), 2011
- •Others who have been diagnosed with nephrectomy according to the researcher's judgment
- •Colon and Rectal Surgery
- •A person who needs to have a resection for colon and rectal cancer
- •Histopathologically confirmed by adenocarcinoma of the rectum or colon
- •No remote transition (M0)
- •Primary tumor without other peripheral organ involvement (T1-T4a)
- •When intestinal obstruction is not accompanied In case of elective surgery
- •Does not require resection of any organ other than the primary tumor
- •Others who have been diagnosed as having to need colon and rectal resection according to the researcher's judgment
排除标准
- •Common Standard
- •If you have mental illness or serious systemic disease
- •Body Mass Index (BMI) ≥ 30, high obesity
- •General anesthesia is not possible due to uncontrolled bleeding tendency or lowering of cardiopulmonary function
- •If you have a positive or reactive pregnancy
- •Patients who wish to undergo conventional laparoscopy or da Vinci robotic surgery
- •Pancreaticobiliary tract area surgery
- •If you have a history of open abdominal surgery Liver cirrhosis Patients with abnormally inoperable pancreatobiliary malformations, other pancreatic biliary diseases, or systemic diseases
- •Prostatectomy
- •Surgical removal of prostate tumor is difficult or life expectancy is short
- •Meets the exclusion criteria of prostatectomy below <Exclusion Criteria for Prostatectomy>
- •Clinical study subjects at high risk group Criteria of Prostate Risk Group Prostate High Risk Group Prostate Cancer Stage (T3a and above) or Gleason class ≥ 8 or ≤ 10 or PSA> 20ng / ml
- •* Reference) NCCN (National Comprehensive Cancer Network), 2015
- •Have a history of surgery on the prostate, urethra, or bladder neck
- •If you have a history of open surgery
- •Nephrectomy
- •If you have a history of epigastric open surgery or have had kidney surgery
- •History of chronic inflammation in the kidneys and the posterior cavity
- •prone to bleeding 3) When a disease such as kidney or vascular malformation is impossible to the extent that surgery is impossible
- •Colon and Rectal Surgery
- •If you have a history of lower abdominal and pelvic laparotomy
- •prone to bleeding
- •If you are older than 80 years old
- •In case of remote transition (M1)
- •When long-term complications other than adjacent organ invasion (T4b) or primary tumor are needed
- •Accompanied by intestinal obstruction, perforation, or emergency surgery
研究组 & 干预措施
pancreaticobiliary disease
Experimental
10 pancreaticobiliary disease cases
干预措施: Revo-i robotic surgery system (Model MSR-5100) (Procedure)
Urinary tract disease
Experimental
13 urinary tract disease cases
干预措施: Revo-i robotic surgery system (Model MSR-5100) (Procedure)
Colon disease
Experimental
10 colon disease cases
干预措施: Revo-i robotic surgery system (Model MSR-5100) (Procedure)
结局指标
主要结局
Operation success rate
时间窗: 24hours after operation
Surgery is complete without significant complications up to 24 hours after surgery and without conversion to other operations (laparotomy or laparoscopy)
次要结局
- Operative outcome(1 month after operation)
研究者
研究点 (2)
Loading locations...
相似试验
Unknown
不适用
Laparoscopic Augmented Reality for Identification of Liver Lesions - a Pre-clinical Randomized Cross-over TrialLaparoscopyAugmented RealityOrientation, SpatialLiverNCT05389241Universitätsklinikum Köln72
已完成
不适用
A Prospective, Multicenter Observational Study on MAST™ (Minimal Access Spinal Technologies) Fusion Procedures for the Treatment of the Degenerative Lumbar SpineDegenerative Lumbar Spine Causing Back and/or Leg PainLumbar Spine DegenerationNCT01143324Medtronic Spinal and Biologics255
招募中
不适用
Surgically Treated Displaced Mid-diaphyseal Clavicle FracturesClavicle FractureNCT05867355University of Calgary111
Unknown
不适用
The LightPath® Breast Cancer StudyBreast CancerNCT02666079Lightpoint Medical Limited170
已完成
不适用
Study of Primary Surgical Treatment of Nasolacrimal Duct Obstruction in Children Less Than Four Years OldNasolacrimal Duct ObstructionNCT00315289Jaeb Center for Health Research973